We report on p27 and cyclin E immunoreactivity (IR) in 86 patients with myelodysplastic syndromes (MDS). No association was found between cyclin E IR and survival in the whole series. Cyclin E IR was more prevalent in patients with refractory anemia (RA) and RA with ringed sideroblasts (RARS) with poor survival, although this trend was not statistically significant.
|Titolo:||The prevalence and clinical relevance of p27 and cyclin E immunoreactivity in myelodysplastic syndromes|
|Parole Chiave:||Cyclin E; Myelodysplasyic syndromes; p27|
|Settore Scientifico Disciplinare:||Settore MED/15 - Malattie del Sangue|
|Data di pubblicazione:||gen-2003|
|Appare nelle tipologie:||01 - Articolo su periodico|